Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06240091 · ClinicalTrials.gov registry record · NA
Potency and Precision Investigation
A NA study, sponsored by Woebot Health.
- Completed
- Registry status
- NA
- Development phase
- 203
- Enrollment target
NCT06240091: Completed NA study, sponsored by Woebot Health.
NCT06240091 is a NA study that has completed, run by Woebot Health. The registered enrollment target is 203 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (86% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06240091, a NA study, has completed, sponsored by Woebot Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 203 participants
- Enrollment target
Study Summary
The overarching goal of this study is to establish initial proof of mechanism for precision interventions in an adult population.
Primary Outcome
Measure of working alliance. A 12-item measure that assesses three key aspects of the therapeutic alliance: (a) agreement on the tasks of therapy, (b) agreement on the goals of therapy, and (c) development of an affective bond. For the purposes of the study, the word "therapist" was replaced with "Woebot". Total mean scores range from 1-5, with higher scores indicating greater alliance between the participant and Woebot.
Interventions
- DEVICE DISC-MA
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 203 participants |
| Start Date | 2024-03-13 |
| Est. Completion | 2024-05-09 |
| Phase | NA |
What the finished NCT06240091 record still lists
NCT06240091 is an interventional study that assigns participants to a tested intervention. The registered 203 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (86% lower).
The record links to 0 conditions, and to 1 intervention - of which DISC-MA is the first listed.
NCT06240091 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06240091 about?
NCT06240091 is a clinical study titled "Potency and Precision Investigation". The overarching goal of this study is to establish initial proof of mechanism for precision interventions in an adult population.
What is the current status of trial NCT06240091?
This trial is currently completed. It is a NA study. The enrollment target is 203 participants. The study started on 2024-03-13. Estimated completion is 2024-05-09.
What interventions are being tested in trial NCT06240091?
The interventions under investigation include: DISC-MA (DEVICE).
Who is sponsoring clinical trial NCT06240091?
This trial is sponsored by Woebot Health, which has 13 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
203 504th of 2000 higher than 1,496 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05652686 · 203 participants · Phase 1
A Study of Peluntamig (PT217) in Patients With Neuroendocrine Carcinomas Expressing DLL3 (the SKYBRIDGE Study)
- NCT06063122 · 203 participants · NA
Development of a Therapeutic Device to Improve Speech Sound Differentiation in Preterm Infants
- NCT07031245 · 203 participants · NA
Evidence-Based Quality Improvement to Reduce VA Primary Care Burnout
- NCT03481010 · 204 participants · NA
Periacetabular Osteotomy With and Without Arthroscopic Management of Central Compartment Pathology
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI